Company:  TAKEDA PHARMACEUTICAL CO ... (TKPYY)
Form Type:  20FR12B
Filing Date:  12/6/2018 
CIK:  0001395064 
Address:  1-1, DOSCHOMACHI 4-CHOME 
City, State, Zip:  CHUO-KU, OSALCA 540-8645,  00000 
Last Trade
Last Trade: 
$16.79  
Change: 
-1.04 (-5.83%)  
Trade Time: 
Dec 07  
Market Cap: 
$26.69B
Trade TKPYY now with 

© 2018  
Description of Business
We are a global, research and development-driven pharmaceutical company with a presence in more than 70 countries. We bring highly-innovative, life-changing medicines to patients across the globe, with prescription drugs marketed directly or through our partners in approximately 100 countries worldwide. Our global workforce of more than 27,000 employees is committed to bringing better health and a brighter future to patients. We develop and market pharmaceutical products to treat a broad range of medical conditions including GI diseases, cancer, neurological and psychiatric diseases and other medical conditions, including diabetes and hypertension, as well as vaccines. We are also committed to our corporate social responsibility program, which is dedicated to global health, and our access to medicine strategy, which aims to increase access to innovative and potentially life-saving medicines for patients with some of the highest unmet medical needs across the world.
Register and access this filing in:     
  FORM 20FR12B
    PART I
      Item 1. Identity of Directors, Senior Management and Advisers
      Item 2. Offer Statistics and Expected Timetable
      Item 3. Key Information
      Item 4. Information on the Company
      Item 4A. Unresolved Staff Comments
      Item 5. Operating and Financial Review and Prospects
        Factors Affecting Our Results of Operations
        B. Liquidity and Capital Resources.
          CASH FLOW
          INCOME STATEMENT
      Item 6. Directors, Senior Management and Employees
        NAME AND TITLE
        NAME AND TITLE
        NAME AND TITLE
        NAME AND TITLE
      Item 7. Major Shareholders and Related Party Transactions
        BENEFICIAL OWNERS
      Item 8. Financial Information
        Legal Proceedings
      Item 9. The Offer and Listing
      Item 10. Additional Information
      Item 11. Quantitative and Qualitative Disclosures about ...
      Item 12. Description of Securities Other Than Equity Securities
    PART II
      Item 13. Defaults, Dividend Arrearages and Delinquencies.
      Item 14. Material Modifications to the Rights of Security ...
      Item 15. Controls and Procedures.
      Item 16A. Audit Committee Financial Expert.
      Item 16B. Code of Ethics.
      Item 16C. Principal Accountant Fees and Services.
      Item 16D. Exemptions from the Listing Standards for Audit ...
      Item 16E. Purchases of Equity Securities by the Issuer and ...
      Item 16F. Change in Registrant's Certifying Accountant.
      Item 16G. Corporate Governance.
      Item 16H. Mine Safety Disclosure
    PART III
      Item 17. Financial Statements
      Item 18. Financial Statements
      Item 19. Exhibits
    SIGNATURES
    Report of Independent Registered Public Accounting Firm
    CASH FLOW
    CASH FLOW
    Notes to Consolidated Financial Statements
    REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
    BALANCE SHEET
    INCOME STATEMENT
    INCOME STATEMENT
    CASH FLOW
    CASH FLOW
    CASH FLOW
    BALANCE SHEET
    INCOME STATEMENT
    INCOME STATEMENT
    INCOME STATEMENT
    BALANCE SHEET
    INCOME STATEMENT
    INCOME STATEMENT
    CASH FLOW
    BALANCE SHEET
    INCOME STATEMENT
    CASH FLOW
  EXHIBIT 1.1
    Article 24. (Delegation of a Decision on the Execution of ...
  EXHIBIT 1.2
  EXHIBIT 1.3
    Article 19 (Method of Requesting Additional Purchase)
  EXHIBIT 2.1
  EXHIBIT 10.1
  EXHIBIT 10.5
  EXHIBIT 10.6
  EXHIBIT 10.7
  EXHIBIT 10.8
  EXHIBIT 10.9
  EXHIBIT 10.10
  EXHIBIT 10.11
  EXHIBIT 10.12
  EXHIBIT 10.13
  EXHIBIT 10.14
  EXHIBIT 15.1
  EXHIBIT 15.2
  EXHIBIT 99.1
    INCOME STATEMENT
    INCOME STATEMENT
    BALANCE SHEET
    CASH FLOW
    Notes to Condensed Interim Consolidated Financial Statements ...
    BALANCE SHEET